Efficacy of short-term corticosteroid therapy in outpatient treatment of acute bronchial asthma

1983 ◽  
Vol 75 (2) ◽  
pp. 259-262 ◽  
Author(s):  
Stanley B. Fiel ◽  
Morris A. Swartz ◽  
Karen Glanz ◽  
Mildred E. Francis
1976 ◽  
Vol 14 (8) ◽  
pp. 31-32

Attacks of asthma in most children are relatively mild, but in a few they are severe and potentially fatal.1 The severity of attacks can be reduced by β-adrenoceptor stimulants, theophylline compounds and sodium cromoglycate, but when these are not effective it may be necessary to give a corticosteroid continuously. For those children who develop a severe exacerbation despite maintenance treatment, or those who get infrequent but often severe attacks that do not respond to bronchodilators, a short high-dose course of a corticosteroid can be given, and many practitioners choose to give this to their patients at home.2 However since no trials of such treatment have been performed the benefit remains unproven.


2010 ◽  
Vol 16 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Kotaro Oe ◽  
Tsutomu Araki ◽  
Haruhiko Ogawa ◽  
Akikatsu Nakashima ◽  
Katsuaki Sato

1990 ◽  
Vol 21 (2) ◽  
pp. 38-44 ◽  
Author(s):  
Joan Randell ◽  
Lorinda Arella ◽  
Sherry Deren ◽  
Charles Lyles ◽  
Mary Ellen Winfield

This paper describes an intervention designed to enhance the integration of vocational services in an outpatient treatment setting. The position of “vocational integrator” was created and implemented in two clinics to (a) raise the importance of vocational services, (b) develop vocational skills and resources available to staff, and (c) review and implement policies to facilitate vocational programming. The sequence of tasks necessary to develop and implement this position, and issues arising for the integrators and the clinics are described. Results indicated that some short term increases in vocational activities were found, and a longer time period may be needed to assess the long term impact of this type of intervention.


Digestion ◽  
1990 ◽  
Vol 47 (2) ◽  
pp. 115-120 ◽  
Author(s):  
Tomasz Laskus ◽  
Janusz Cianciara ◽  
Teresa Loch ◽  
Janusz Slusarczyk

1978 ◽  
Vol 6 (6) ◽  
pp. 452-454
Author(s):  
S Urdinovic ◽  
K Karoussos

The authors report on their experience with combined etomidate anaesthesia in 500 varied surgical procedures including thoracic and neurosurgery. Specific indications for the new short-term hypnotic etomidate are dealt with, including anaesthesia in poor-risk patients, conditions of shock, spastic bronchitis, and bronchial asthma. When used for the induction of neuroleptic analgesia, etomidate offers certain benefits. Since it induces few side-effects, it is suggested that this preparation is the drug of choice for ambulatory anaesthesia, Caesarean section, etc.


2020 ◽  
Vol 17 (5) ◽  
pp. 467-471
Author(s):  
Tatiana A. Kaliuzhnaia ◽  
Marina V. Fedoseenko ◽  
Leyla S. Namazova-Baranova ◽  
Firuza Ch. Shakhtakhtinskaya ◽  
Arevaluis M. Selvyan ◽  
...  

This article refutes one popular-science review that has appeared on the MDedge news site in January 2020. It has stated that there was no effect of vaccination with 7-valent pneumococcal conjugate vaccine (PCV-7) against invasive forms of Streptococcus pneumoniae in children with bronchial asthma. The author of this publication refers to the article «Asthma and the Risk of Invasive Pneumococcal Disease: A Meta-analysis» that described episodes of invasive pneumococcal disease and pneumonia development in children with bronchial asthma and in healthy children who was vaccinated with pneumococcal conjugate vaccine. It was concluded that the PCV-7 provides limited protection against colonization only with vaccine pneumococcus serotypes (according to the obtained data), and, thus, there was high risk of carriage of non-included serotypes in children with bronchial asthma (BA). The analysis of the article mentioned above has revealed that the representativeness of the data is extremely low. For example, the study groups were selected incorrectly, the PCV-7 administration scheme was not analyzed, whereas its violation may cause ineffective immunity development and as result disease development. Another crucial aspect is the lack of any data on the BA severity and inhaled corticosteroid therapy in vaccinated children. Nowadays, there are numerous scientific studies on the clinical efficacy of PCV in the prevention of IPD including the children with BA. Most world-class experts support the necessity of PCV-7 usage in children with BA for the prevention of IPD and suggest their patients over 6 years old on inhaled corticosteroid therapy to perform additional administration of pneumococcal polysaccharide vaccine.


Sign in / Sign up

Export Citation Format

Share Document